SKINTEK LABS INC
NT 10-Q, 2000-11-14
NON-OPERATING ESTABLISHMENTS
Previous: DIABETEX INTERNATIONAL CORP, 10-12G/A, 2000-11-14
Next: NEOFORMA COM INC, 10-Q, 2000-11-14





                    U.S. SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON D.C. 20549               SEC File #
                                                                  000-27565
                                   FORM 12b-25
                           NOTIFICATION OF LATE FILING            Cusip #
                                                                       378904403

Form 10-K [ ]   Form 20-F [ ]   Form 11-K [ ]   Form 10-Q [X]   Form N-SAR

                      For Period Ended: September 30, 2000
                                      ----------------
                       [ ] Transition Report on Form 10-K
                       [ ] Transition Report on Form 20-F
                       [ ] Transition Report on Form 11-K
                       [ ] Transition Report on Form 10-Q
                       [ ] Transition Report on Form N-SAR
                    For the Transition Period Ended: ________________________
-----------------------------------------------------------------------------
|                                                                           |
|Read Instruction (on back page) Before Preparing Form, Please Print or Type|
|                                                                           |
| Nothing in this form shall be construed to imply that the Commission has  |
|              verified any information contained herein.                   |
-----------------------------------------------------------------------------
If            the notification relates to a portion of the filing checked above,
              identify the Item(s) to which the notification relates:

------------------------------------------------------------------------------
PART I - REGISTRANT INFORMATION
------------------------------------------------------------------------------
Full Name of Registrant:
                                            Skintek Labs, Inc.
------------------------------------------------------------------------------
Former Name if Applicable

------------------------------------------------------------------------------
Address of Principal Executive Office (Street and Number)
           1750 NW 65th Ave. Plantation FL 33313
------------------------------------------------------------------------------
City, State, Zip Code

PART II - RULES 12b-25 (b) AND (c)

If the subject report could not be filed without  unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)

     (a) The reasons  described  in  reasonable  detail in Part III of this form
         could not be eliminated without unreasonable effort or expense;
     (b) The subject annual report,  semi-annual  report,  transition  report on
         Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof, will be
XX       filed on or before the fifteenth calendar day following the prescribed
--       due date; or the subject quarterly report of transition report on Form
         10-Q, or portion thereof will be filed on or before the fifth calendar
         day following the prescribed due date; and
     (c) The accountant's  statement or other exhibit required by Rule 12b-25(c)
         has been attached if applicable.



<PAGE>

PART III - NARRATIVE

State below in reasonable  detail the reasons why Forms 10-K,  20-F, 11-K, 10-Q,
N-SAR or the transition  report or portion thereof could not be filed within the
prescribed time period.

In an effort to complete and update other  required  filings with the Commission
and to insure accuracy and continuity, we were not able to complete the required
financial  statements  for this period on a timely basis.  We expect to file the
required report within the allotted extension.

PART IV - OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this
    notification:

  Carter Read                        954              454-6015
----------------------------   -----------------   ---------------
     (Name)                       (Area Code)       (Telephone No.)

(2) have all other  periodic  reports  required under section 13 or 15(d) of the
Securities  Exchange Act of 1934 or section 30 of the Investment  Company Act of
1940  during  the  preceding  12  months  or for such  shorter  period  that the
registrant was required to file such report(s) been filed?  If the answer is no,
identify report(s).
                                                        [x]Yes  [ ]No
------------------------------------------------------------------------------

(3) Is it anticipated that any significant  change in results of operations from
the  corresponding  period for the last  fiscal  year will be  reflected  by the
earnings statements to be included in the subject report or portion thereof?
                                                        [ ]Yes  [x]No

If so, attach an explanation of the  anticipated  change,  both  narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.

------------------------------------------------------------------------------


                               Skintek Labs, Inc.
                     ------------------------------------------
                 (Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.

Date: 11/13/00                            By: /s/ Carter Read
     -----------------------------       -------------------------------------
                                                  Carter Read

INSTRUCTION; The form may be signed by an executive officer of the registrant or
by any other duly  authorized  representative.  The name and title of the person
signing  the form  shall  be typed or  printed  beneath  the  signature.  if the
statement is signed on behalf of the registrant by an authorized  representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.



<PAGE>

                                    ATTENTION
Intentional misstatements or omissions of fact constitute Federal Criminal
                        Violations (See 18 U.S.C. 1001).

                              GENERAL INSTRUCTIONS

1.  This form is  required  by Rule  12b-25 (17 CRF  240.12b-25)  of the General
    Rules and Regulations under the Securities Exchange Act of 1934.

2.  One signed  original and four  conformed  copies of this form and amendments
    thereto  must be  completed  and  filed  with the  Securities  and  Exchange
    Commission,  Washington,  D.C.  20549,  in  accordance  with Rule 0-3 of the
    General Rules and Regulations under the Act. The information contained in or
    filed with the form will be made a matter of public record in the Commission
    files.

3.  A manually  signed copy of the form and  amendments  thereto  shall be filed
    with each national  securities  exchange on which any class of securities of
    the registrant is registered.

4.  Amendments to the  notifications  must also be filed on form 12b-25 but need
    not restate information that has been correctly furnished. The form shall be
    clearly identified as an amended notification.

5.  ELECTRONIC  FILERS.  This form shall not be used by electronic filers unable
    to timely file a report solely due to electronic difficulties. Filers unable
    to submit a report within the time period  prescribed due to difficulties in
    electronic  filing  should  comply  with  either  Rule  201 or  Rule  202 of
    Regulation S-T (Section 232.201 or Section 232.202 of this chapter) or apply
    for an adjustment  in filing date  pursuant to Rule 13(b) of Regulation  S-T
    (Section 232.13(b) of this chapter).


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission